Treatment of osteoporosis in clinical practice: first experience with the Russian generic drug of zoledronic acid

Treatment of osteoporosis in clinical practice: first experience with the Russian generic drug of zoledronic acid

Objective: to evaluate the effect of the generic drug of zoledronic acid on bone mineral density (BMD) and markers of bone metabolism in patients with osteoporosis (OP), as well as possible long-term adverse reactions (AR) 12 months after drug administration.Patients and methods. The study included...

Full description

Saved in:
Bibliographic Details
Main Authors: N. V. Toroptsova, A. O. Efremova, T. A. Korotkova, O. V. Dobrovolskaya, N. V. Demin, A. Yu. Feklistov, E. Yu. Samarkina, M. V. Cherkasova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2022-05-01
Series:Современная ревматология
Subjects:
osteoporosis
zoledronic acid
bone mineral density
fractures
bone metabolism
Online Access:https://mrj.ima-press.net/mrj/article/view/1275
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://mrj.ima-press.net/mrj/article/view/1275

Similar Items